2019-03-04T20:51:35-06:00 2018-05-31 PIERCY BOWLER TAYLOR & KERN 6100 ELTON AVE SUITE 1000 LAS VEGAS NV 89107 990 2017-06-01 880189404 NEVADA CANCER RESEARCH FOUNDATION INC % SHANNON YULE NEVA 7023840013 601 SOUTH RANCHO DRIVE Suite C26 LAS VEGAS NV 89106 SHANNON YULE PROGRAM COORDINATOR 7023840013 2018-10-11 true JEFF EDWARDS P00400349 7023841120 24.120.204.250 88074320190635000010 2019-03-04 P 44719A76F37E5613402BCC72D60904937AA7605D 73F2412722A14177A96FF71563645E3C74249765 2017 2019-02-21 02:37:17Z SHANNON YULE 601 SOUTH RANCHO DRIVEC26 LAS VEGAS NV 89106 1103232 false X SNCRF.ORG X 1983 NV CANCER RESEARCH 3 2 22 4 0 742280 918909 644557 173820 82 10503 0 0 1386919 1103232 0 0 0 0 820982 910003 0 0 0 480117 367768 1301099 1277771 85820 -174539 472440 311671 66914 80684 405526 230987 CANCER RESEARCH false false 809760 COOPERATIVE GROUP ONCOLOGY TRIALS. PATIENTS WERE TREATED IN CORRELATION WITH VARIOUS RESEARCH PROGRAMS WITH FOLLOW-UP AND SUBMISSION OF DATA ON 420 PATIENTS. 176358 173820 INDUSTRY SPONSOR TRIALS. 12 PATIENTS ARE TREATED USING VARIOUS CANCER RELATED PHARMACEUTICALS WITH FOLLOW-UP AND SUBMISSION OF DATA. 986118 true true false false false false false false false false true false false false true false true false false false false false false false false false false false false false false false false true false false false false false false false false false false false false false true 2 0 true 22 true false false false false false false false false false false false false false false false X 3 2 false false false false false false false true true false false true true true true true true true true false X SHANNON YULE 7023840013 601 SOUTH RANCHO DRIVE SUITE C26 LAS VEGAS NV 89106 JOHN ELLERTON MD PRESIDENT/TREASURER 5.0 0.0 X 30000 0 0 BRUCE BORGELT MD DIRECTOR 0.0 0.0 X 0 0 0 JIM CHRISTENSEN MD SECRETARY 0.0 0.0 X 0 0 0 SHANNON YULE PROGRAM COORDINATOR 40.0 0.0 X 83024 0 0 113024 0 0 0 false false false NA NONE 0 900274 18635 918909 REIMBURSEMENTS 541700 47457 PHARMACEUTICALS 541700 126363 173820 129 0 0 0 0 0 10374 0 0 0 0 0 0 0 0 0 0 1103232 0 0 0 0 113024 83024 30000 0 0 586320 425443 160877 0 147361 108764 38597 63298 49751 13547 0 0 10500 8295 2205 0 0 0 209862 203676 6186 0 14837 14837 0 0 72096 72096 20844 17442 3402 0 441 280 161 12500 12500 0 23510 23510 3178 2510 668 1277771 986118 291653 0 84628 17449 320878 194577 0 0 0 0 1087 782 0 0 0 0 0 0 0 0 238181 139318 65847 98863 0 0 0 0 0 0 0 0 0 0 472440 311671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 66914 80684 66914 80684 X 405526 230987 0 0 0 0 405526 230987 472440 311671 -174539 X false true X true true true X 440268 992020 781923 742280 918909 3875400 212441 317162 658654 644557 173820 2006634 0 0 0 652709 1309182 1440577 1386837 1092729 5882034 0 0 0 0 0 0 0 5882034 59 66 69 82 129 405 0 59 66 69 82 129 405 0 10374 10374 652768 1309248 1440646 1386919 1103232 5892813 0.99817 1.00000 0.00007 0.00008 X false false 7373 6013 1360 229783 132280 97503 1025 1025 98863 0 CAPITAL LEASE OBLIGATIONS 80684 80684 1263892 245906 245906 1017986 85246 85246 1103232 1517346 245906 -6331 239575 1277771 1277771 FORM 990, SCHEDULE D, PART XII, LINE 2d 2016 ACCOUNTS PAYABLE 32,313 2016 PAYROLL TAXES PAYABLE 2,112 2016 ACCRUED PAYROLL 19,666 2016 ACCRUED VACATION 11,902 2016 PREPAID EXPENSES -26,851 2017 ACCOUNTS PAYABLE -3,145 2017 PAYROLL TAXES PAYABLE -5,880 2017 ACCRUED PAYROLL -25,593 2017 ACCRUED VACATION -14,824 2017 PREPAID EXPENSES 16,631 ------- 6,331 FORM 990, SCHEDULE D, PART XI, LINE 4b 2016 ACCOUNTS RECEIVABLE 13,158 2016 RESEARCH RECEIVABLE 3,573 2016 GRANT RECEIVABLE 211,414 2016 PHARM RECEIVABLE 232,884 2016 ACCOUNTS REC-CCDR 55,800 2016 ACCOUNTS REC-WELLS FARGO 3,652 2017 ACCOUNTS RECEIVABLE -4,475 2017 RESEARCH RECEIVABLE -3,573 2017 GRANT RECEIVABLE -215,360 2017 PHARM RECEIVABLE -169,594 2017 ACCOUNTS REC-CCDR -42,233 -------- 85,246 JOHN ELLERTON OFFICER EXPENSES X 782 782 false true false 782 FORM 990, PART VI, SECTION B, LINE 11A THE PROGRAM ADMINISTRATOR, PROGRAM COORDINATOR, AND THE PRINCIPAL INVESTIGATOR WILL REVIEW FORM 990 AND DISCUSS WITH EACH OTHER ANY QUESTIONS AND/OR COMMENTS. THE PROGRAM ADMINISTRATOR WILL DIRECT THESE QUESTIONS TO THE TAX PREPARERS AND RELAY THE ANSWERS TO THE PROGRAM COORDINATOR AND PRINCIPAL INVESTIGATOR AND DETERMINE IF THEY ARE SATISFIED WITH THE RESPONSE AND NO FURTHER ACTION WILL BE REQUIRED. IF THEY ARE NOT SATISFIED, THEN A MEETING WILL BE SCHEDULED TO DISCUSS THE ISSUES WITH THE TAX RETURN PREPARERS. FORM 990, PART VI, SECTION B, LINE 12c ALL INVESTIGATORS WHO PARTICIPATE IN CLINICAL TRIALS ARE REQUIRED TO COMPLETE A FORM FDA 1572 ANNUALLY AND SUBMIT IT TO THE FOOD AND DRUG ADMINISTRATION. THE FORM FDA FORM 1572 IS A STATEMENT OF INVESTIGATOR (TITLE 21, CODE OF FEDERAL REGULATIONS (CFR) PART 312). IT INCLUDES A SUBPART, FINANCIAL DISCLOSURE FORM, WHICH THE INVESTIGATOR MUST ALSO COMPLETE ANNUALLY. IN ADDITION TO COMPLETING THE FORM FDA 1572, INVESTIGATOR AND FOUNDATION STAFF MUST ALSO COMPLETE AN ANNUAL FINANCIAL CONFLICT OF INTEREST DISCLOSURE FORM. THE POLICY AND PROCEDURES FOLLOWED BY THE FOUNDATION ARE INTENDED TO MEET THE MOST RECENT REQUIREMENTS PUBLISHED BY THE FEDERAL GOVERNMENT REGARDING REVISED FINANCIAL CONFLICT OF INTEREST (FCOI) REGULATION, PROMOTING OBJECTIVITY IN RESEARCH ON AUGUST 25, 2011 (42 CFR PART 50 SUBPART F AND 45 CFT PART 94). THE FOUNDATION WILL REPORT SIGNIFICANT FINANCIAL CONFLICTS OF INTEREST AS OUTLINED IN THE FEDERAL REGULATIONS. FORM 990, PART VI, SECTION B, LINE 15 THE FOUNDATION USES DATA AS TO COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS AT SIMILAR ORGANIZATIONS. FOUNDATION EMPLOYEES ARE EVALUATED ANNUALLY AND THE RATE OF PAY IS DISCUSSED DURING THE EVALUATION AND IS WRITTEN AS PART OF THE EVALUATION PROCESS. THESE ARE THE RECORDS WITH RESPECT TO THE DECISIONS REGARDING THE COMPENSATION PROCESS. THE PRINCIPAL INVESTIGATOR IS COMPENSATED PER FEDERAL GUIDELINES. NONE OF THE OTHER TRUSTEES RECEIVE COMPENSATION. FORM 990, PART V, LINE 3b NEVADA CANCER RESEARCH FOUNDATION, INC DOES NOT CONDUCT A REGULARLY CARRIED ON UNRELATED TRADE OR BUSINESS WHICH IS NOT SUBSTANTIALLY RELATED TO THE PERFORMANCE BY THE ORGANIZATION OF ITS EXEMPT PURPOSES. FORM 990, PART VI, SECTION C, LINE 19 IF AN INQUIRY IS MADE, THEN THE PROGRAM ADMINISTRATOR, AFTER CONSULTATION WITH THE PRINCIPAL INVESTIGATOR, RESPONDS. FORM 990, PART V, LINE 14B FOUNDATION DOES NOT OFFER TANNING SERVICES AND RECEIVED NO PAYMENTS FOR TANNING SERVICES DURING THE FISCAL YEAR. FORM 990 PART IX LINE 11G DESCRIPTION:DUES AND SUBSCRIPTIONS TOTAL FEES:19933 FORM 990 PART IX LINE 11G DESCRIPTION:LAB FEES TOTAL FEES:45805 FORM 990 PART IX LINE 11G DESCRIPTION:OUTSIDE SERVICES TOTAL FEES:108463 FORM 990 PART IX LINE 11G DESCRIPTION:POSTAGE TOTAL FEES:7946 FORM 990 PART IX LINE 11G DESCRIPTION:EQUIPMENT RENTAL TOTAL FEES:3259 FORM 990 PART IX LINE 11G DESCRIPTION:SERVICE CHARGES TOTAL FEES:333 FORM 990 PART IX LINE 11G DESCRIPTION:MILEAGE TOTAL FEES:8322 FORM 990 PART IX LINE 11G DESCRIPTION:TELEPHONE AND UTILITIES TOTAL FEES:15801